Bringing New Horizons to Therapy


General News

Ablatherm® HIFU posters receive best poster awards at EAU 2012 in Paris

Among the 7 Ablatherm® HIFU poster presentations at EAU 2012 in Paris, 2 posters have been awarded "Best Posters" highlighting HIFU clinical data relevance.

Marc Oczachowski, EDAP's Chief Executive Officer, commented, "This confirms the recognition and acceptance of HIFU as one of the hottest topic in modern urology. It validates the support from the international urology community for Ablatherm-HIFU's positioning as a complement to surgery in addressing prostate cancer and proven ability to bring minimally invasive treatment to patients and urologists."

Print This Page